These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Trajectories of response in schizophrenia-spectrum disorders: A one-year prospective cohort study of antipsychotic effectiveness. Drosos P; Johnsen E; Bartz-Johannessen CA; Larsen TK; Reitan SK; Rettenbacher M; Kroken RA World J Psychiatry; 2022 Mar; 12(3):521-532. PubMed ID: 35433321 [TBL] [Abstract][Full Text] [Related]
6. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
12. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia. Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402 [TBL] [Abstract][Full Text] [Related]
13. Study on the prescribing patterns of antipsychotic medication in a rural England Community Mental Health Team. Seshadri M; Elsemary A; Thalitaya MD; Chikodzore L; Nagalingam P Psychiatr Danub; 2017 Sep; 29(Suppl 3):524-529. PubMed ID: 28953820 [TBL] [Abstract][Full Text] [Related]
14. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
15. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Keefe RS; Seidman LJ; Christensen BK; Hamer RM; Sharma T; Sitskoorn MM; Lewine RR; Yurgelun-Todd DA; Gur RC; Tohen M; Tollefson GD; Sanger TM; Lieberman JA Am J Psychiatry; 2004 Jun; 161(6):985-95. PubMed ID: 15169686 [TBL] [Abstract][Full Text] [Related]
17. Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Cuesta MJ; Peralta V; Zarzuela A Schizophr Res; 2001 Mar; 48(1):17-28. PubMed ID: 11278151 [TBL] [Abstract][Full Text] [Related]
18. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study. Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A; Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925 [TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia. Lindenmayer JP; Khan A; Iskander A; Abad MT; Parker B J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705 [TBL] [Abstract][Full Text] [Related]
20. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]